Elevation in plasma alkaline phosphatase level during rhG-CSF administration. Granulocytopenic patients with gynecologic cancers treated with cancer chemotherapy

Gynecologic and Obstetric Investigation

Volumn 45, Issue 2, 1998, Pages 99-104

  Fukumasu, Hiroshi ^a   Fukumasu, Yasuko ^a   Ogita, Sachio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alkaline phosphatase; Cancer chemotherapy; Neutrophil; Neutrophil alkaline phosphatase; Recombinant human granulocyte colony stimulating factor

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PIRARUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CELL MATURATION; CLINICAL ARTICLE; CLINICAL TRIAL; ENZYME ACTIVITY; FEMALE; GRANULOCYTOPENIA; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL;

ADULT; AGED; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENTS; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; ISOENZYMES; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; OVARIAN NEOPLASMS;

EID: 0031931193     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000009934     Document Type: Article

References (28)

1. Molineux G, Pojda Z, Dexter TM: A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 1990;75:563-569.
2. Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK., Testa NG, Dexter TM: Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987;56:809-813.
3. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R: Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988;26:667-672.
4. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Tagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-1422.
5. Fossa SD, Poulsen JP, Aserud AA: Alkaline phosphatase and lactate dehydrogenase changes during leukocytosis induced by G-CSF in testicular cancer (letter). Lancet 1992;340:1544.
6. Maiche AG, Muhonen T, Porkka K: Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatment. Lancet 1992;340:853.
7. Ogawa M, Masaoka T, Mizoguchi H, Takaku F, Nakashima M: A phase three study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma. A multi-institutional placebo controlled double-blind comparative study. Jpn J Cancer Chemother 1990;17:365-373.
8. Ogawa M, Takaku F, Mizuno M, Aso Y, Miura Y, Shimoyama M, Saijo N, Toyama K, Mizoguchi H, Masaoka T, Kimura I: Early phase two clinical study of KRN8601 (rhG-CSF). J Clin Ther Med 1989;5:1841-1857.
9. Ogawa M, Masaoka T, Takaku F: Phase II study of KRN 8601 (rhG-CSF) in patients with neutropenia induced by chemotherapy for malignant lymphoma. J Clin Ther Med 1990;6:23-43.
10. Kato Y, Yamamoto M, Ikegami J, Okumura S, Hara T, Shuto K: A possible mechanism of increase in serum alkaline phosphatase activity in rats given granulocyte colony-stimulating factor. Exp Anim 1996;45:23-32.
11. Charuruks N, Krailadsiri P, Voravud N: Leukocyte alkaline phosphatase activity and peripheral changes of granulocyte colony-stimulating factor. J Med Assoc Thai 1996;79:801-807.
12. Tomonaga M, Sasaki T, Okuzaki M: Studies on leukocyte alkaline phosphatase: Use of the naphthol AS-MX phosphate fast-blue RR staining method. Acta Haematol Jpn 1963;26:179-192.
13. Katoh M, Shirai T, Shikoshi K, Ishii M, Saito M, Kitagawa S: Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: Neutrophil alkaline phosphatase activity as an endogenous marker. Eur J Haematol 1992;49:19-24.
14. Yuo K, Kitagawa S, Okabe T, Urabe A, Komatsu Y, Itoh S, Takaku F: Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 1987;70:404-411.
15. Mishler JM, Williams DM: Alkaline phosphatases a marker of maturity in human neutrophils. J Clin Pathol 1980;33:555-561.
16. Kabutomori O, Tokuda M, Arai T, Myozin S, Inaoka Y, Kawanishi K: A new method for biochemical measurement of enzymatic activity of intracellular alkaline phosphatase in neutrophils. J Clin Exp Med 1989;150:155-156.
17. Hayhoe FGJ, Quaglino D: Cytochemical demonstration and measurement of leukocyte alkaline phosphatase activity in normal and pathological states by a modified azodye coupling technique. Br J Haematol 1958;4:375-389.
18. Yuo A, Kitagawa S, Osaka A, Ohta M, Miyazono K, Okabe T, Urabe A, Saito M, Takaku F: Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 1989;74:2144-2149.
19. Sato N, Mizukami H, Tani K, Asano S: Regulation of mRNA levels of alkaline phosphatase gene in neutrophilic granulocytes by granulocyte colony stimulating-factor and retinoic acid. Eur J Haematol 1991;46:107-111.
20. Roilides E, Walsh TJ, Pizzo PA, Rubin M: Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991;163:579-583.
21. Wang JM, Chen ZG, Colella S, Bonilla MA, Welte K, Bordignon C, Mantovani A: Chemotactic activity of recombinant human granulocyte colony-stimulating facator. Blood 1988;72:1456-1460.
22. Osaka A, Kitagawa S, Sakamoto S, Miura Y, Takanashi N, Takaku F, Saito M: In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor. Blood 1989;74:2743-2748.
23. Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden JR, Platzer E: Neutrophil express the high affinity receptor for IgG(FcγRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 1991;78:885-889.
24. Fujisawa M, Kobayashi Y, Okabe T, Takaku F, Komatsu Y, Itoh S: Recombinant human granulocyte colony stimulating factor induces granulocytosis in vivo. Jpn J Cancer Res (Gann) 1986;77:866-869.
25. Babior BM: Oxidants from phagocytes: Agents of defense and destruction. Blood 1984;64:959-966.
26. Fink ME, Fink SC: Serum muramidase and granulocyte turnover (abstract). Clin Res 1966;14:316.
27. Hansen HE, Karle H, Andersen V, Olgaard K: Lysozyme turnover in man. J Clin Invest 1972:51:1146-1155.
28. Binder RA, Gilbert HS: Muraminidase in polycythemia vera. Blood 1970;36:228-232.